Status:
COMPLETED
A Study to Assess Wound Healing Efficacies of Different Adhesive Bandages
Lead Sponsor:
Johnson & Johnson Consumer Inc. (J&JCI)
Conditions:
Wound Healing
Eligibility:
All Genders
25-55 years
Phase:
NA
Brief Summary
The purpose of this study is to assess the wound healing efficacy (time to complete healing) of different adhesive bandages.
Eligibility Criteria
Inclusion
- Fitzpatrick Skin Type II or III
- Uniform skin color on both volar forearms
- Generally in good health based on medical history reported by the participant
- -Individual has signed the Photographic Release and Informed Consent Documents along with (HIPAA) disclosure
- Willing to have temporary (semi-permanent) dot-tattoos applied to the volar forearms
Exclusion
- Has known allergies, hypersensitivity, or adverse reactions to anesthetics, adhesive bandages, latex, wound treatment products, or any component/ingredient present in the Investigational Products (IPs)/auxiliary/ancillary products
- Has a known history of a blood-clotting disorder, keloid formation, or a cardiovascular, hepatic, or renal disease
- Presents with a skin condition that would, in the opinion of the PI or Study Physician, confound study results, increase risk to participant, or interfere with study evaluations
- Has excessive hair or tattoos on either volar forearm
- Has a known history of severe systemic immune system disorders
- Has self-reported Type 1 or Type 2 diabetes
- Has self-reported uncontrolled chronic diseases
- Is taking medication that would mask an adverse event, confound study results or alter/compromise the bleeding/healing process
- Is self-reported to be pregnant or planning to become pregnant
- Has a body mass index (BMI) above 35
- Is self-reported to be an alcohol or drug abuser
- Has participated in another clinical trial within 10 days
- Either is or lives with someone who is a current employee of any company that makes/markets adhesive bandages or first-aid products
Key Trial Info
Start Date :
August 9 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2019
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04040933
Start Date
August 9 2019
End Date
October 30 2019
Last Update
July 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thomas J. Stephens
Richardson, Texas, United States, 75081